Why Sampling Time Is Part of Mechanism Discrimination
Two biological mechanisms can produce nearly identical measurements at one stage of a response and markedly different measurements later. For example, a delayed inhibitory feedback loop may only alter a biomarker after the initial response has developed. Similarly, mechanisms that both reduce a biomarker may predict different rates of recovery. A sampling schedule that misses those periods can leave the mechanisms difficult to distinguish, even if their full time courses differ.
The design question here is specifically when to measure. For a fixed biomarker, intervention, and set of competing mechanisms, compare the predicted measurements at candidate times while accounting for the variability that can obscure their differences. This is a design criterion, not a claim that a particular mechanism is true. The earlier material on designing experiments and expected information gain provides broader perspectives; here the emphasis is on translating time-course contrasts into practical sampling choices.
Build the Criterion From Predictions and Variability
The predictions should correspond to the actual design: the same biomarker, dose or intervention, time origin, and population being considered. The numerator is a contrast in the measurement’s units. The denominator is a standard deviation in those same units, so \(d(t)\) has no units. A large raw difference is not necessarily useful if the measurement is also highly variable.
For a simple setting, suppose individual \(i\)'s measurement under mechanism \(M_m\) at time \(t\) is
where \(b_i(t)\) represents between-subject variation and \(\epsilon_i(t)\) represents assay error. If both terms have mean zero, are independent of one another, and have variances \(\tau^2(t)\) and \(\sigma^2(t)\), respectively, then the total variance for an individual measurement is
This variance is for an individual observation. If the design compares sample means from \(n\) independent subjects and the two mechanisms have the same variance, the variance of the difference in sample means is \(2v(t)/n\). That comparison has a different denominator from the individual-level score. State which design is being scored before using a separation measure.
The simple criterion assumes that the predictive means and variability are meaningful for the intended population, and that observations have the assumed error structure. With repeated measurements, errors and subject effects can be correlated over time. In that case, use a covariance matrix for the full schedule rather than treating every time point as independent.
Why Standardized Separation Is a Useful Starting Point
At one time point, suppose measurements under each mechanism are normally distributed with the same variance \(v(t)\). The log likelihood ratio for an observed value \(y\), comparing \(M_1\) with \(M_2\), is
Taking the expectation under \(M_1\), where \(E_1[Y]=\mu_1(t)\), gives
Thus, under equal-variance normal observation models, \(d(t)^2/2\) is the expected log likelihood ratio in favor of \(M_1\) when \(M_1\) generates the observation. This derivation explains why a squared, noise-scaled contrast is informative. It does not make the score a posterior probability that either mechanism is correct, and the equal-variance normal assumptions matter.
For several times measured on the same subject, let \(\boldsymbol{\mu}_m\) be the vector of predicted means at the selected times, and let \(\Sigma\) be the common covariance matrix of an individual’s measurements, including assay and subject-level variation. The schedule’s squared separation is
This is the multivariate counterpart of \(d(t)^2\), assuming a common, positive-definite covariance matrix. It accounts for correlation: two measurements that tend to move together may contribute less independent information than two uncorrelated measurements with the same marginal variances. For \(n\) independent subjects with the same schedule and fixed model predictions, the squared separation for the sample mean vector scales to \(nD^2\).
Worked Example: Finding a Time That Reveals Delayed Feedback
Suppose two hypothetical mechanisms predict a cytokine concentration after a dose. \(M_1\) includes delayed inhibitory feedback, while \(M_2\) does not. At candidate times, the predicted population means and variability for an individual measurement are as follows. Assume assay error and between-subject variation are independent, and that the listed standard deviations are common to both mechanisms.
| Time after dose (h) | \(\mu_1(t)\) (pg/mL) | \(\mu_2(t)\) (pg/mL) | Assay SD (pg/mL) | Between-subject SD (pg/mL) |
|---|---|---|---|---|
| 1 | 18 | 20 | 1.5 | 2.0 |
| 3 | 12 | 20 | 1.5 | 2.0 |
| 8 | 10 | 12 | 1.5 | 2.0 |
At each time, total variance is \(v=1.5^2+2.0^2=2.25+4.00=6.25\;(\mathrm{pg/mL})^2\), so the total standard deviation is \(2.5\;\mathrm{pg/mL}\). The standardized separations are:
- At 1 h: \(d=|18-20|/2.5=0.800\).
- At 3 h: \(d=|12-20|/2.5=3.20\).
- At 8 h: \(d=|10-12|/2.5=0.800\).
Among these candidate times, 3 h has the largest predicted separation relative to individual measurement variability. If only one time can be sampled, it is the strongest choice under this criterion. The result supports prioritizing 3 h for discrimination; it does not establish that feedback is present or guarantee that one observed value will identify the mechanism.
Choose a Schedule, Not Just an Isolated Time
When more than one sample per subject is feasible, the goal is to choose a set of times jointly. A time with a modest individual contrast can still contribute to a schedule if it adds a distinct temporal pattern. Conversely, several individually promising times may provide redundant information when their measurements are strongly correlated.
Worked Example: Accounting for Correlated Measurements
Consider two candidate mechanisms with predicted mean differences of \(2\;\mathrm{pg/mL}\) at each of two times. Suppose each individual measurement has variance \(4\;(\mathrm{pg/mL})^2\), and the correlation between the two measurements on the same subject is \(0.5\). Then
The schedule’s squared separation is
If the two measurements were incorrectly treated as independent, the calculation would instead be \(2^2/4+2^2/4=2.00\). The higher value overstates separation because it counts the correlated observations as if each supplied an independent contrast. In a real design, the covariance should reflect both assay correlation and repeated-measure subject effects, where those are expected.
Recovery Kinetics and a Practical Design Workflow
Recovery is another setting in which the best time may not be the earliest or latest available. For example, one mechanism might predict slow receptor recycling and another might predict delayed recovery downstream of the receptor. Both may predict a similar nadir after treatment, but different concentrations during recovery. The useful sampling window is where the predicted trajectories differ after scaling by the variability at that time.
Worked Example: Selecting a Recovery Window
Two hypothetical mechanisms predict recovery of a circulating biomarker after an intervention. Consider the following candidate times; the values are population means in ng/mL, and the assay and between-subject standard deviations apply to each individual measurement.
| Time after intervention (days) | \(\mu_1(t)\) (ng/mL) | \(\mu_2(t)\) (ng/mL) | Assay SD (ng/mL) | Between-subject SD (ng/mL) |
|---|---|---|---|---|
| 2 | 8 | 9 | 0.4 | 1.2 |
| 5 | 14 | 20 | 0.4 | 1.2 |
| 9 | 24 | 26 | 0.4 | 1.2 |
The total variance at each time is \(0.4^2+1.2^2=0.16+1.44=1.60\;(\mathrm{ng/mL})^2\), and the total SD is \(\sqrt{1.60}=1.265\;\mathrm{ng/mL}\). Therefore:
- Day 2: \(d=|8-9|/1.265=0.791\).
- Day 5: \(d=|14-20|/1.265=4.74\).
- Day 9: \(d=|24-26|/1.265=1.58\).
Day 5 is the most discriminating of these candidate recovery times, despite the biomarker not being at its highest level then. The design targets a time when the mechanisms predict different values, not simply a time when the biomarker is large.
A practical selection process makes the modeling assumptions visible before optimizing a schedule:
Name the candidate mechanisms, biomarker, intervention, population, and feasible sampling window. Keep the comparison fixed while evaluating candidate times.
Simulate each mechanism at candidate times using parameter values or parameter ranges appropriate to the design question. Check that predictions use the same measurement scale and time origin.
Combine assay and subject variability for a single time point, or construct the full covariance matrix for a repeated-measure schedule. Include correlations when they are expected.
Calculate standardized separation for a single time or Mahalanobis separation for a schedule. Apply sampling, assay-volume, and timing constraints rather than optimizing an infeasible design.
Recalculate under plausible changes to parameter values, variance assumptions, and candidate time grids. Prefer a schedule whose advantage is not dependent on one fragile assumption.
Diagnostics, Alternatives, and Limits
A separation score is a summary of specified predictions and variability, so inspect its ingredients rather than reporting only the winning time. Plot both predicted trajectories and the chosen times. Check whether the apparent contrast is driven by a narrow transient that could be missed because of timing error, or by a region where assay performance is poor. For repeated measurements, check whether the covariance matrix is based on a defensible correlation structure and is invertible. If it is nearly singular, the schedule may contain redundant observations or the covariance estimates may be unstable.
Subject variability deserves particular attention. If it is omitted, the denominator can be too small and the design can favor times whose population means differ but whose individual measurements overlap substantially. If variability differs between mechanisms, the equal-variance criterion is incomplete: variance differences can themselves be informative, but should be evaluated with a criterion based on the full predictive distributions. For non-normal measurements, heavy tails, censoring, or substantial parameter uncertainty, a Gaussian mean-separation score may not reflect actual discrimination. Simulation-based assessment of how often a design distinguishes the mechanisms is then a useful alternative.
| Approach | What it emphasizes | Main caution |
|---|---|---|
| Largest raw mean difference | Absolute contrast in measurement units | Ignores how noisy or variable the measurement is |
| Standardized or Mahalanobis separation | Mean contrast relative to individual variability and correlation | Depends on the assumed predictive means and covariance |
| Expected information gain | Expected change in uncertainty across mechanisms, averaging over possible observations under a specified setup | Requires additional probability and prior specifications; it is not identical to a mean-separation score |
| Simulation-based discrimination performance | How often a specified analysis distinguishes simulated mechanisms | Depends on the simulation assumptions and the analysis rule being evaluated |
The standardized criterion is especially useful for screening candidate times and explaining why a time is promising. It does not account automatically for every design feature, such as dropout, unequal group sizes, cost, parameter uncertainty, or a decision-specific penalty for choosing the wrong mechanism. Nor should a high score be interpreted as causal evidence from data not yet collected. It is a prediction-based design aid: the observed data and a suitable analysis are still needed to assess the mechanisms.
Common Pitfall
Correction: Compare the difference with the variability at each time. If the day-5 difference is 6 ng/mL with a total SD of 8 ng/mL, its individual-level standardized separation is \(6/8=0.75\). A smaller 3 ng/mL difference at another time with a total SD of 1 ng/mL gives \(d=3\), and may be more discriminating under the assumed model. Also account for temporal correlation when choosing multiple times.
Check Your Understanding
Answer each question using the assumptions stated in the question. Brief solutions follow.
- At a candidate time, two mechanisms predict 15 and 19 pg/mL. Assay SD is 1 pg/mL and between-subject SD is 2 pg/mL, independent. Calculate the total SD and standardized separation.
- Why can the time with the largest raw difference between predicted means fail to be the best sampling time?
- Two measurements have equal marginal variance and positive correlation. Why can treating them as independent overstate the value of sampling both times?
- At two candidate recovery times, the mean differences are 2 ng/mL and 4 ng/mL. Their total SDs are 1 ng/mL and 4 ng/mL, respectively. Which has greater standardized separation?
Solutions. (1) The total variance is \(1^2+2^2=5\;(\mathrm{pg/mL})^2\), so the total SD is \(\sqrt{5}=2.236\;\mathrm{pg/mL}\). The separation is \(4/2.236=1.79\). (2) A raw difference ignores assay noise and subject variability; compare the difference after scaling by total SD, and include covariance for a schedule. (3) Positively correlated measurements partly repeat the same information, so the independent calculation counts their contrasts too strongly. (4) The first time has \(d=2/1=2\); the second has \(d=4/4=1\). The first time has greater standardized separation despite the smaller raw difference.